approach to the patient of pleural effusion presented by : dr. vidhu mittal junior resident

70
APPROACH TO THE PATIENT OF PLEURAL EFFUSION Presented by : Dr. Vidhu Mittal Junior Resident Deptt. of Chest and TB 1

Upload: jett

Post on 29-Jan-2016

21 views

Category:

Documents


0 download

DESCRIPTION

APPROACH TO THE PATIENT OF PLEURAL EFFUSION Presented by : Dr. Vidhu Mittal Junior Resident Deptt . of Chest and TB. PLEURAL SPACE. Introduction - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

1

APPROACH TO THE PATIENT OF PLEURAL EFFUSION

Presented by :Dr. Vidhu MittalJunior Resident

Deptt. of Chest and TB

Page 2: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

2

PLEURAL SPACEIntroduction

The pleural space is a potential space around the lungs, bounded by two membranes, the visceral pleura covering the lung and the parietal pleura covering the chest wall and the diaphragm.

Blood Supply of Pleura

The parietal pleura is supplied by intercostal arteries.

The visceral pleura is exclusively supplied by the bronchial circulation which drains into the pulmonary veins.

Page 3: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

3

Lymphatic Drainage

The visceral pleura has extensive lymphatics but they do not connect to the pleural space. The parietal pleura lymphatics connect to the pleural space via stomata, holes of 8-10 m in diameter.

From stoma liquid drains into

Lacunae Spider like submessothelial collecting lymphatics infracostal lymphatics

Systemic Venous System Thoracic Duct Parasternal &

Periaortic Nodes

Page 4: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

4

In a normal pleural space, fluid enters and exists at a constant, equal rate because of the ongoing filtration of a small amount of low protein liquid in normal microvessels. Near the end of the 19th Century, Starling and Tubby hypothesized that the exchange of microvascular fluid and solutes was governed by the balance between the hydrostatic pressure, osmotic pressure and membrance permeability and they devised the starling equation :

QF = LP x A [(PCAP-PPL ) - D (piCAP-piPL)]

QF = Fluid movement

LP = Filtration Coefficient

A = Surface area of the pleura

D = Reflection coefficient for protein movement across the pleura (PL)

P = Hydrostatic pressure of the pulm. capillary bed. (CAP).

Pi= Oncotic pressure of pleural space.

Page 5: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

5

This equation formed the basis for understanding fluid accumulation in the pleural space, where the hydrostatic forces that filter water out of the vessel are balanced by osmotic forces that reabsorb water back into the vessel. In the pleura, reabsorption is facilitated by the extensive lymphatic system on the diaghram and mediastinal surfaces of the parietal pleura.

Normal Characteristics of Pleural Space/Fluid

Major Consideration are given to :-

(a) Volume of pleural fluid

(b) Thickness of Pleural Space

(c) Cellular Components

(d) Physiochemical Factors

Page 6: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

6

(a) Volume :- Normally, the volume of fluid in the right and left pleural spaces is quite similar expressed/kg of bodymass, the total pleural fluid volume in normal non-smoking humans in 0.260.1 ml/kg.

(b) Thickness of space :- The normal pleural space is 18-20 m in width, although it widens at its most dependent areas.

(c) Cellular components :- In the pleural space WBC count has been reported to be 1700 cells/mm3 and the mean RBC count of 700 cells/mm3 and approx. 75% of the cells are macrophages and 25% are lymphocytes, with mesothelial cells, neutrophils and eosinophils accounting for <2% each.

Page 7: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

7

(d) Physiochemical Factors :-

Protein : A small amount of protein is normally present in pleural fluid and is similar to serum fluid except for former contain more of LMW albumin.

HCO3 Bicarbonate conc. is increased by 20-25% relative to that in

plasma.

NA+ reduced by 3% to 5%

Cl- reduced by 6% to 9%

Concentration of K+ and glucose in the pleural fluid & plasma appears to be nearly identical.

Pathophysiology :- For pleural liquid to accumulate to form an effusion it is likely that both the entry rate of liquid must increase and the exit rate must decrease.

Page 8: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

8

If only the entry rate increased it would require a sustained rate more than 30 times normal to exceed the reserve lymphatic removal capacity; if the exit rate decreased it would take more than a month at the normal entry rate at 12ml/day to produce an effusion detectable by chest radiograph.

Increased entry rate Decreased exist of liquidMay result from ed filtration May result from interferenceacross systemic or pulm. capillaries with lymphatic function (e.g.)

• Obst. of parietal pleura stomata. • Inhibition of lymphatic contractility • Infiltration of draining parasternal

lympha nodes. • Elevation of systemic venous

pressure into which the lymph drains.

Page 9: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

9

HOW TO APPROACH : (1) Clinical Signs and Symptoms :- Common symptoms of patients with effusion are pleuritic chest pain, cough and dyspnoea and it appears that the three symptoms are due to different causes.

(a) Pleuritic chest pain :- it is derived from inflammation of the parietal pleura. Some patients with pleural effusions experience a dull aching chest pain rather than pleuritic chest pain which suggests patient has pleural malignancy.

Page 10: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

10

(2) Second symptoms for pleural effusion is dry, non-productive. The exact mechanism for cough is not clear.

(3) Third symptom is dyspnoea. Pleural effusion acts as a space occupying process in the thoracic cavity and therefore reduces all the subdivisions of lung volumes.

Physical Examination :-

Inspection : While inspecting it is important to examine the relative sizes of the hemithoraces and the intercostal spaces.

(a) If the pleural pressure is increased on the side of the effusion, that hemithorax will be larger and usual concavity of ICSs will be blunted or even convex.

(b) Whereas if the pleural pressure on the side of effusion is decreased (as with obstruction of major bronchus or a trapped lung). The ipsilateral hemithorax will be smaller and the normal concavity of ICS will be exaggerated.

(c) In addition with inspiratory efforts, the intercostal spaces retract.

Page 11: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

11

Palpation :

(a) Is useful for delineating the extent of effusion in areas where pleural fluid separates the lung from the chest wall, tactile fremetus is absent or accentuated.

(b) With a thin rim of fluid, the percussion note may still be resonant, but the TF is diminished.

(c) Palpation may also reveal that the cardiac point of maximum impulse is shifted to one side or the other.

Percussion :- The percussion not over a pleural effusion is dull or flat. The dullness is maximum at the lung bases where the thickness of the fluid is greatest.

Page 12: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

12

Auscultation :-

Auscultation over the pleural fluid characteristically reveals decreased or absent breath sounds.

• Near the superior border of the fluid, however, breath sounds may be accentuated and take on a bronchial characteristic.

• Auscultation may also reveal a pleural rub. pleural rubs often appear as pleural effusions diminish in size, either spontaneously or as a result of treatment because the pleural fluid is no longer present between the roughened pleural surfaces.

• Obviously the chest is not the only structure that should be examined when evaluating a patient with a pleural effusion, clues to the origin of the effusion are often present elsewhere.

Page 13: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

13

1 CHF Cardiomegaly, neck vein distension or peripheral edema.

2 Rheumatoid or Lupus erythematosis

Signs of joint disease or subcut. nodules.

3 Metastatic Disease • Enlarged nontender nodular liver.• Hypertrophic osteo arthropathy.

4 Subdiaphragmatis Process

• Abdominal Tenderness

5 Cirrhosis & hepatothorax

• Tense Ascitis

6 Lymphoma, sacrodosis

• Lymphadenopathy

Page 14: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

14

Separation of Exudates from Transudates

A diagnostic thoracocentesis should be performed on nearly every patient with free pleural fluid that measures >10mm on the decubitus radiograph.

If the patient has obvious CHF, consideration can be given to postponing the thoracentosis until the heart failure is treated.

Thoracacentesis procedure :-

• Is a safe procedure and may be much safer when guided by USG but due to cost and inaccessibility USG is accompanied in high risk cases only.

• Because of the small bore of the needle required, it can be safely performed in patients with coagulopathies and thrombocytopenia.

Page 15: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

15

Descriptions of Technique emphasizes on :• Proper positioning of the patient.

• Identification of the area of decreased tactile fremitus.

• Adequate local anaesthesia of parietal pleura as well as skin.

• The needle should run over the top of the rib to avoid the neurovascular bundle that travels in the middle of the intercostal space from the spine for approx. 5-6 inches before taking its safer position beneath the upper rib. Thus one should avoid thoracocentesis medial to midclavicular line.

• Complication from thoracocentesis include :-

• Pneumothorax (2-6%)

• hemothorax (1%)

Page 16: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

16

The risk for pneumothorax is higher in patients.

• With prior radiotherapy to the chest.

• Multiple prior thoracocentesis

• Use of vaccum bottles.

• The first question that should be answered with the diagnostic thoracoceatesis is whether the patient has a transudative or an exudative pleural effusion.

1) Light's Criteria :-

(a) Pleural fluid protein-to-serum protein ratio > 0.5

(b) Pleural fluid LDH - to - serum LDH > 0.6.

(c) Pleural fluid LDH > 2/3 of the upper normal limit for serum.

Page 17: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

17

But this criteria may misidentify a transudative effusion as an exudative effusion in as many as 25% of cases. If a patient appears to have a transudative effusion clinically, additional tests can be assessed to verify its transudative etiology.

(a) If the difference between the protein conc. of serum and the pleura exceeds 3.1 gm/dl the patient in all probability has a tranudative effusion.

(b) If pleural concentrations of N-terminal brain natruretic peptide (NT-BNP) are >1300 pg/ml the patient likely has a transudate from a cardiac cause.

Page 18: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

18

Differentiating Among Various Exudative Pleural Effusions :-

Once it has been determined that the patient has an exudative pleural effusion attempt is made to find out the cause.

The various tests done that can eb done are :-

(1) Appearance of pleural fluid :-

The gross appearance and the odor of the pleural fluid is to be noted.

Page 19: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

19

Cause Fluid Appearance / Odor• Pseudochylothorax & Chycothorax• Urinothorax• Anaerobic empyema• Chylothorax• Aspergillus infection• Empyema• Amebic liver abscess• Esophageal rupture• Trauma/pul embolism/ malignancy, benign asbestor related, pneumonia or after MI syndrome.

Milky white

Ammonical urinePutridBile stainedBlackTurbidAnchovy BrownFood particlesBlood stained

Page 20: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

20

PLEURAL FLUID IS BLOODY

Hematocrit of pleural fluid

>50% of peripheral blood 1-50% <1%

Hemothorax Malignant Pleural No clinical

Disease/Pulm. Significance

Chest tube embolus/trauma

induced

Page 21: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

21

PLEURAL FLUID IS TURBID OR MILKY

Centrifugation

Turbidity clears Turbidity Persists

In due to cells or debris in Chylothorax or

pleural fluid Pseudochylothorax

Page 22: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

22

Results of Fluid Analysis

Pseudochylothorax Chylothorax

• TG level

• Cholesterol level

• Cholesteral crystals

•Chylomicrons

• <50 mg/dl

• >200 mg/dl

• Yes, common

• No

• Disease process is usually chronic & pleural surfaces are thickened

> 110 mg/dl< 200 mg/dlNo YesDisease process is usually acute 2 pleural surfaces not thickened.

Page 23: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

23

Pleural Fluid Protein :-

It is generally not useful in the differential diagnosis of exudative pleural effusion as these tends to be elevated to a comparable degree with all exudative pleural effusion.

However :-

To label it exudative effusion protein > 2.9 gm/dl

If protein is >5g/dl likelihood of tuberculous pleurisy is increased.

Page 24: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

24

Pleural Fluid LDH :

Whereas pleural liquid protein and LDH arise from filtration from serum and thus serves as indication of vascular premeability LDH as an intracellular enzyme, may also indicate the degree of cell turnover and/or the degree of inflammation within the pleural space. The pleural fluid LDH level is increased to a comparable degree inpatients with all categories of exudative pleural effusion.

• However, pleural fluid LDH level should be measured everytime thoracocentesis is performed.

Page 25: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

25

Pleural Fluid Glucose :-

A low glucose concentration probably indicate the co-existence of two abnormalities : a thickened, infilterated pleura leading to an impaired diffusion of glucose into the pleural space plus increased metabolic activity leading to increased glucose utilization within the pleural space.

• Demonstration of pleural fluid glucose <60mg/dl narrows the diagnostic possibilities to 7.

• Parapneumonic effusion Malignant Effusion

TuberculousRheumatoid ParagonimiasisChurg - Strauss - Syndrome

Page 26: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

26

If a patient with parapneumonic effusion has a pleural fluid glucose <40mg/dl tube thoracostomy is considered.

Pleural Fluid White Cell Count and Differential :-

Pleural liquid that is submitted for white cell count and differential should be sent in a tube with an anticoagulant to prevent the cells from clumping.

The differential cell count on the pleural fluid is much more useful than the white cell count itself. The normal pleural space contains predominnalty macrophages (75%)

lymphocytes (23%)

Page 27: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

27

For pleural fluid differential count, cells are partitioned into :-

• Polymorphonuclear leukocytes.

• Eosinophils

• Small lymphocytes

• Mesothelial cells and

Other mononuclear cells.

Pleural effusion due to an acute disease contain predominantly polymorphonuclear leucocytes.

Due to chronic diseae predominanlty mononuclear cells.

Page 28: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

28

Pleural fluid eosinophilia :-

• Most commonly due to air or blood in the pleural space.

• Can also be due to drugs like nitrofurantoin or dantrolene.

• Small lymphocytes when >50% of WBC's in an exudative pleural effusion indicates that patient may either has a malignant or a tuberculous pleural effusion. Hence, the presence of pleural fluid lymphocytosis should alert the physician to consider needle biopsy of pleural for diagnosis.

Page 29: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

29

Pleural fluid cytology :-

• The first pleural fluid cytologic study is positive for malignant cells in upto 60% and is 3 separate specimens 90% of effusion due to pleural malignancy.

• The frequency of positive pleural fluid cytologic tests is depedent on the tumor type. For e.g. <25% of patients with Hodgkins disease have the positive cytology, whereas most patients with adeno carcinoma have positive cytology.

Page 30: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

30

Other diagnostic tests for malignancy :-

Cytology may be non diagnostic either because of a problem of specificity or sensitivity.

(a) Fish fluorescent in situ hybridization with chromosome specific probes that can confirm abnormal numbers of specific chromosomes.

(b) Early findings of malignancy including DNA methylation can be detected by methylation specific PCR.

(c) Gene expression patterns can help distinguish mesothelioma and adenocarcinoma.

Page 31: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

31

Culture & Bacteriological Stains :-

Pleural fluid should be sent for culture for bacteria, mycobacteria and fungi along with gram's stain.

The newer adjuncts are :-

(1) Detection of bacterial antigens via CIE or latex agglutination or of bacterial DNA by PCR.

(2) Antigen specific assays especially in children against most common pathogens like staphlococcus, streptococcus and H.influenza.

(3) Amplification and sequencing of bacterial 16s ribosomal RNA.

Page 32: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

32

Other Diagnostic Tests for Pleural Fluid

Pleural Fluid pH and pCO2

The pleural fluid pH is most useful in determining whether

chest tubes should be inserted in patients with

parapneumonic effusion as a fall in pH i.e. <7.2 is an

indication for ICCT.

In general pleural fluid much a low pH also have a

low glucose hence glucose level can be used as an

alternative as measuring pH require the similar condition

of measurement as measuring arterial pH.

Page 33: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

33

Other Diagnostic Tests for Pleural Fluid

Pleural Fluid Amylase:-

Pleural fluid amylase is elevated in patients with effusion

secondary to

esophageal perforation.

• Pancreatic disease

• Malignancy

•As first 2 are rare causes of effusion so amylase levels are usually

not done.

• Malignancy can be differentiated from pancreatic disease with

amylase isoezymes because the amylase with malignant effusion is

primarily of the salivary type.

Page 34: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

34

Tests for collagen vascular disease:

•About 5% of patients with rheumatoid arthritis and 50% of patients

with SLE have a pleural effusion during the course of the disease or

may be the first manifestation of disease.

•Measurement of ANA litre is the best screening test for lupus pleuritis

although it is now evident that a positive pleural fluid ANA is not

specific for the diagnosis.

Rheumatoid Arthiritis :

• When a rheumatoid pleural effusion is suspected, the clinical picture

usually establishes the diagnosis but patients with rheumatoid

pleuritis have a pleural fluid RA factor titre of 1:320 and serum titre.

Page 35: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

35

Adenosine Deaminase

• The pleural fluid ADA levels are elevated in almost all

patients with tuberculous pleuritis and remains a sensitive

marker for tuberculous pleurisy in pateints with HIV also.

• As it is a highly sensitive test it can be useful to exclude

the diagnosis of tuberculosis when the ADA level is low

(<40 U/L).

Page 36: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

36

Interferon - (IFN-)

• Pleural fluid IFN- is elevated almost exclusively in

tuberculous effusions.

•However IFN- release assays had variable results and

have not added to the use of ADA or IFN- measurements

for the diagnosis or exclusion of active pleural

tuberculosis.

Page 37: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

37

Molecular Techniques for diagnosis of mycobacterium tuberculosis

(a) PCR to detect specific mycobacterial DNA sequences

in clinical specimens.

(b) Nucleic acid probes to identify the organism in culture.

(c) RFLP to compare strains in epidemologic studies.

(d) Gene based susceptibility studies to screen for known

genes associated with drug resistance.

Page 38: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

38

Page 39: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

39

USEFUL RADIOGRAPHIC TESTS IN PATIENTS WITH SUSPECTED PLEURAL DISEASE

1) Chest Radiography:-

Two main factors influence the distribution of free fluid

in the pleural space.

(a) Fluid collects in the most dependent part of the

thoracic cavity because the lung is less dense than the

pleural fluid.

(b) Because of their, elastic recoil the lobes of the lung, if

normal, maintain their traditional shape at all stages of

collapse.

Page 40: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

40

• If Fluid is < 75 ml, in upright position fluid first

accumulates between inferior surface of the lower lobe

and diaphragm without overflowing into the costphrenic

sinuses.

• The presence of a clinically significant amount of free

pleural fluid can be excluded if both posterior costophrenic

angles are clear.

• When there are larger amounts of pleural fluid the

lateral costophrenic angle on the PA radiograph becomes

blunted.

Page 41: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

41

• Lateral decubitus radiographs should be obtained in

most instances when free pleural fluid is suspected as, as

little as 5ml of pleural fluid can be demonstrated with

properly exposed decubitus radiographs.

• We can also semiquantitate the amount of pleural fluid

by measuring the distance between the inner border of the

chest wall and the inner border of the lung as when this

distance is <10mm, the amount of pleural fluid is small

and a diagnostic thoracocentesis is usually not attempted.

Page 42: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

42

Page 43: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

43

• Pleural fluid may become encapsulated by adhesions

anywhere between the visceral and parietal pleura or

interlobar fissures.

•When the loculation is situated between the lung and the

chest wall, there is a characteristic radiographic 'D-shaped'

loculation seen with the base of D against the chest wall and

the smooth convexity protruding inward toward the lung.

•The absence of air bronchograms helps differentiate

between a loculated pleural effusion and a parenchymal

infilterate.

•A definate diagnosis of loculated pleural effusion is best

established by USG or CT.

Page 44: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

44

• For semiquantitation of pleural fluid Blackmore et al

demonstrated that if > 750ml of pleural fluid (is

present)

• Visible on lateral radiograph as a memories positively.

• >200 ml - menesin can be identified in the lateral

costophrenic angle of the PA radiograph.

• > 500ml - menesive observes the entire

hemidiaphragm.

Page 45: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

45

Ultrasonography

• In context with the pleural effusion USG is useful in

following situations:

(a) Determining whether pleural fluid is present.

(b) Marking the site for appropriate thoracocentesis.

(c) Identification of pleural fluid loculation.

(d) Distinction of pleural fluid from pleural thickening.

(e) Semiquantitation of the amount of pleural fluid.

Page 46: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

46

Ultrasonography

• A 2-5 MHz curvilinear probe allows visualization of the

deeper structures and the sector scan field allows a wider

field of view through a small acoustic window.

• The best distinguishing characteristic of pleural fluid

collection on ultrasound is that it changes its shape with

respiration.

Page 47: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

47

Page 48: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

48

Positioning:-

• Posterior chest - patient sitting upright

• Anterior and lateral chest - lateral decubitus position.

• If patients arm is raised above his head the distance

between the rib spaces is increased and this facilitates

scanning the patient in erect or recumbent position.

Page 49: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

49

• Apart from the above uses one more use of USG is in ICU.

• USG helps to diagnose pleural effusion in supine patients in

ICU as many chest radiograph are taken with the patient in

the supine position and pleural effusions are often missed.

• Identification of pleural effusion in ICU patients in is

important for atleast 2 reasons:-

(a) If the patient in on ventilator removal of the fluid may

facilitate weaning.

(b) If the patient is febrile, it is important to ascertain whether

the patient has infected pleural fluid.

Page 50: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

50

Advantages of USG over CT Scan

• Ease and speed with which examination can be done.

• Availability of portable units hence useful for bedside

examination in seriously ill patients.

• Lack of ionizing radiation.

• Low cost.

• USG is also useful to evaluate pleural effusion due to

pulmonary embolism.

Page 51: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

51

Pleural effusion

S/o pulmonary Colour

embolism doppler of lower Positive Treat for

extremities thrombo embolism

Negative

Proceeds to lung V/Q Scan

or CT angio

Where CT angio is > sensitive and specific and can diagnose alternate

diagnosis.

Page 52: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

52

Page 53: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

53

Computed Tomography (CT Scan):

1. CT chest has it greatest utility in distinguishing

parenchymal and pleural abnormalities as between lung

abscess and loculated empyema.

Empyema Lung Abscess

•Cavity walls are of uniform thickness both internally and externally and adjacent lung is usually collapsed.

* Walls of the cavity are not of uniform thickness and the adjacent lung is not compressed.

• The angle of contact with the chest mall may be obtuse.

•Acute

• Most empyemas have lenticular shape and demonstrate the split pleura sign.

Page 54: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

54

Page 55: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

55

2. Distinguish between malignant and benign

causes in diffuse pleural disease as features

associated with malignancy are:-

(a) Circumferential pleural thickening

(b) Pleural nodules

(c) Parietal thickening >1 cm and

(d) Mediastinal pleural involvement.

Page 56: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

56

3. When free fluid lies in posterior costophrenic

recess adjacent to the diaphragm, it may be difficult to

differentiate from ascitis. So several CT signs have been

described for differentiated pleural effusion from ascitis.

(a) Displaced crus sign:-

Pleural effusion Ascites

Displacement of diaphragmatic crus away from the spine by the fluid.

Ascites lies anterior and lateral to the crus.

Page 57: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

57

(a) Interface Sign:-

(b) Diaphragm sign

(c) Bare area sign: restriction of ascitis by the coronary

ligaments from the base area of the liver indicates

ascitis.

Ascitis Pleural Effusion

If present a sharp interface between fluid and liver / spleen.

Line much less distinct.

Pleural Effusion Ascitis

Fluid present outside the diaphragm

Fluid present inside the diaphragm.

Page 58: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

58

Magnetic Resonance Imaging

Pleural effusions generally have a long T1 and T2

values. The intensity of pleural effusion is therefore

low to extremely low on T1 weighted images.

However, at the present time MRI of chest is less

satisfactory than USG or CT in identifying the

presence of pleural fluid, major limitation being the

respiratory and cardiac motion.

Page 59: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

59

INVASIVE TESTS IN PATIENTS WITH UNDIAGNOSED

EXUDATIVE PLEURAL EFFUSION

Three main factors which necessitates the

aggressive approach for the diagnosis in pleural

effusion :.

Page 60: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

60

(a) Sign and symptom of the patient are not improving with

time.

(b) Serial LDH level after thoracocentesis if increases after

each aspiration.

(c) Patient himself is anxious to know the cause.

The various invasive tests that can be done

(d) Needle biopsy of pleura.

(e) Image guided pleural biopsy

(f) Bronchoscopy

(g) VATs

(h) Open biopsy of pleura.

Page 61: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

61

Page 62: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

62

Needle biopsy of the pleura

•Because needle biopsy of the pleura is useful mainly to

establish the diagnosis of malignant or tuberculous

pleural effusion, this procedure should be considered

when one of these diagnosis is suspected.

• Needles most commonly used are COPE needle and

ABRAMS needle.

• Procedure is usually blind or also called closed needle

biopsy.

Page 63: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

63

• In malignant pleural disease the needle biopsy of the pleura will

be positive in 40-60% of patients. But it should be considered

only if the initial pleural fluid cytology after thoracocentesis is

non diagnostic. • It has greater utility for tuberculous pleuritis than malignancy.

The initial biopsy is positive for granulomas in 50-80% of

patients and the demonstrations of granulomas on pleural

biopsy is virtually diagnostic of tuberculous pluritis, caseous

nacrosis or acid fast bacilli need not to be demonstrated. • The greatest value of needle biopsy for a patients with

tuberculosis is obtaining material for culture for mycobacterium

tuberculosis for the determination of drug susceptibility.

Page 64: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

64

Complications

• Pneumothorax : in about 1% of pleural biopsies.

• Hemothorax can result if an intercostal artery or vein is in

advertantly biopsied.

IMAGE GUIDED PLEURAL BIOPSY

Situations in which the pleural effusion is small or there is

loculation or pleural thickening without an effusion, CT image

guided pleural biopsy is an excellent choice.

Page 65: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

65

BRONCHOSCOPY

If the patient of undiagnosed pleural effusion has associated

parenchymal lesion or hemoptysis, fibreoptic bronchoscopy will

provide diagnosis in nearly 75% of patients and in <10% time in

patients with no parenchymal lesion. And for confirming the

parenchymal lesions CT scan is usually done prior to bronchoscopy.

PLEUROSCOPY OF VIDEO ASSISTED THORACOSCOPIC SURGERY

(VATS)

Pleuralscopy can be performed by pulmonologist using local

anaesthesia and conscious sedation for direct visualization of

pleural services, tissue sampling and pleurodesis;

Page 66: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

66

Thoracoscopy performed by thoracic surgeons generally referred

to as VATS utilizes general anaesthesia and single lung ventilation

by double lumen intubation and allows greater access to the

pleura and lung surface.

(1) In patients who are strong suspect for malignancy but pleural

fluid cytology or needle biopsy is inconclusive, this can make

diagnosis in over 80% of cases of malignancy including

mesothelioma.

(2) Also insufflation of talc may be carried out to control the

pleural effusion.

Page 67: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

67

DISADVANTAGES

(1) Risks of the procedure.

(2) Need for post procedure chest tubes.

(3) Cost

OPEN BIOPSY OF THE PLEURAL

Thoracotomy with direct biopsy of the pleura provides the best

visualization of the pleural and the best biopsy specimen.

The main indication for open pleural biopsy is progressive

undiagnosed pleural disease that cannot be approached by or has

failed to be diagnosed by thoracoscopy.

Page 68: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

68

It is important the remember that no diagnosis is established

for approximately 20% of all exudative pleural effusions and that

many resolve spontaneously, leaving no residua.

Page 69: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

69

Page 70: APPROACH TO THE PATIENT OF PLEURAL EFFUSION  Presented by : Dr.  Vidhu Mittal Junior Resident

70